| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,666,000 | 2,615,000 | 2,357,000 | 2,734,000 | | Cost of Revenue | 2,158,000 | 2,004,000 | 1,929,000 | 2,812,000 | | | Gross Profit | 508,000 | 611,000 | 428,000 | (78,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 324,000 | 338,000 | 328,000 | (301,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 162,000 | 150,000 | 150,000 | 154,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,000 | 123,000 | (50,000) | 69,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,000 | 27,000 | (19,000) | (122,000) | | Earnings Before Interest And Taxes | 23,000 | 150,000 | (69,000) | (53,000) | | Interest Expense | 43,000 | 43,000 | 38,000 | 30,000 | | Income Before Tax | (20,000) | 107,000 | (107,000) | (83,000) | | Income Tax Expense | (4,000) | 16,000 | (16,000) | (27,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,000) | 91,000 | (91,000) | (56,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,000) | 91,000 | (91,000) | (56,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,000) | $91,000 | ($91,000) | ($56,000) |
|
0.50% Nasdaq 
Income Statement
